Cartel Problem Is 'Spilling Over To The United States': Texas Senator

Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery. In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks: 12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight. 9 mg dose: average weight loss of 64.4 pounds, or 25.9%. 4 mg dose: average weight loss of 47.2 pounds, or 19% Ahead of the results,...

SpaceX Acquires Cursor AI In $60 Billion Deal As Coding Agent Race Heats Up SpaceX has agreed to acquire AI coding startup Cursor for $60 billion, giving Elon Musk's artificial intelligence empire a leg up in the chatbot coding race currently led by frontier AI labs such as OpenAI, Anthropic, and Google. The Cursor acquisition was announced in a SpaceX 8-K filing with the SEC on Tuesday morning. Details of the deal show that Cursor shareholders will receive SpaceX Class A common stock, implying a Cursor equity value of $60 billion. The...

France Is World's Most Dangerous Place For Bitcoiners: 90 Attacks In 7 Months Authored by Christina Comben via CoinTelegraph.com, French authorities have recorded 90 cases involving kidnapping, abduction, extortion, threats, and violent theft related to cryptocurrencies in just over seven months. The figures, provided to Cointelegraph by the French Interior Ministry, are from Jan. 1 to mid-August 2026. Authorities also recorded 223 arrests, and 126 people were imprisoned from January to July. The figures equate to a new case every two and a half days, although there is no official year-on-year comparison to...